Mira Karrasch1, Petri Tiitta2, Bruce Hermann3, Juho Joutsa4, Shlomo Shinnar5, Juha Rinne4, Anu Anttinen6, Matti Sillanpää7. 1. 1Department of Psychology,Åbo Akademi University,Turku,Finland. 2. 2Department of Public Health,University of Turku,Finland. 3. 4Department of Neurology,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin. 4. 5Turku PET Centre,University of Turku and Turku University Hospital,Finland. 5. 6Division of Clinical Neurosciences,University of Turku and Turku University Hospital,Finland. 6. 7Department of Clinical Neurophysiology,University of Turku and Turku University Hospital,Finland. 7. 9Departments of Public Health and Child Neurology,University of Turku,Finland.
Abstract
OBJECTIVES: Little is known about the very long-term cognitive outcome in patients with childhood-onset epilepsy. The aim of this unique prospective population-based cohort study was to examine cognitive outcomes in aging participants with childhood-onset epilepsy (mean onset age=5.3 years) five decades later (mean age at follow-up=56.5 years). METHODS: The sample consisted of 48 participants with childhood-onset epilepsy and 48 age-matched healthy controls aged 48-63 years. Thirty-six epilepsy participants were in remission and 12 continued to have seizures. Cognitive function was examined with 11 neuropsychological tests measuring language and semantic function, episodic memory, and learning, visuomotor function, executive function, and working memory. RESULTS: The risk of cognitive impairment was very high in participants with continuing seizures; odds ratio (OR)=11.7 (95% confidence interval [CI] (2.8, 49.6), p=.0008). They exhibited worse performances across measures of language and semantic function, and visuomotor function compared to participants with remitted epilepsy and healthy controls. In the participants with remitted epilepsy, the risk of cognitive impairment was somewhat elevated, but not statistically significant; OR=2.6 (95% CI [0.9, 7.5], p=.08). CONCLUSIONS: Our results showed that the distinction of continued versus discontinued seizures was critical for determining long-term cognitive outcome in childhood-onset epilepsy. Few participants in remission exhibited marked cognitive impairment compared to age-matched peers. However, a subgroup of participants with decades long active epilepsy, continuous seizure activity and anti-epileptic drug (AED) medication, showed clinically significant cognitive impairment and are thus in a more precarious position when entering older age. (JINS, 2017, 23, 332-340).
OBJECTIVES: Little is known about the very long-term cognitive outcome in patients with childhood-onset epilepsy. The aim of this unique prospective population-based cohort study was to examine cognitive outcomes in aging participants with childhood-onset epilepsy (mean onset age=5.3 years) five decades later (mean age at follow-up=56.5 years). METHODS: The sample consisted of 48 participants with childhood-onset epilepsy and 48 age-matched healthy controls aged 48-63 years. Thirty-six epilepsyparticipants were in remission and 12 continued to have seizures. Cognitive function was examined with 11 neuropsychological tests measuring language and semantic function, episodic memory, and learning, visuomotor function, executive function, and working memory. RESULTS: The risk of cognitive impairment was very high in participants with continuing seizures; odds ratio (OR)=11.7 (95% confidence interval [CI] (2.8, 49.6), p=.0008). They exhibited worse performances across measures of language and semantic function, and visuomotor function compared to participants with remitted epilepsy and healthy controls. In the participants with remitted epilepsy, the risk of cognitive impairment was somewhat elevated, but not statistically significant; OR=2.6 (95% CI [0.9, 7.5], p=.08). CONCLUSIONS: Our results showed that the distinction of continued versus discontinued seizures was critical for determining long-term cognitive outcome in childhood-onset epilepsy. Few participants in remission exhibited marked cognitive impairment compared to age-matched peers. However, a subgroup of participants with decades long active epilepsy, continuous seizure activity and anti-epileptic drug (AED) medication, showed clinically significant cognitive impairment and are thus in a more precarious position when entering older age. (JINS, 2017, 23, 332-340).
Entities:
Keywords:
Aging; Language; Neuropsychology; Seizure; Semantic function; Visuomotor function
Authors: Bruce P Hermann; Michael Seidenberg; Christian Dow; Jana Jones; Paul Rutecki; Abhik Bhattacharya; Brian Bell Journal: Ann Neurol Date: 2006-07 Impact factor: 10.422
Authors: Kathy N Speechley; Mark A Ferro; Carol S Camfield; Wenyi Huang; Simon D Levin; Mary Lou Smith; Samuel Wiebe; Guangyong Zou Journal: Neurology Date: 2012-09-26 Impact factor: 9.910
Authors: Camille Garcia-Ramos; Sam Bobholz; Kevin Dabbs; Bruce Hermann; Juho Joutsa; Juha O Rinne; Mira Karrasch; Vivek Prabhakaran; Shlomo Shinnar; Matti Sillanpää Journal: Hum Brain Mapp Date: 2017-04-03 Impact factor: 5.038
Authors: Juho Joutsa; Juha O Rinne; Bruce Hermann; Mira Karrasch; Anu Anttinen; Shlomo Shinnar; Matti Sillanpää Journal: JAMA Neurol Date: 2017-05-01 Impact factor: 18.302
Authors: Charlotte DiStefano; Rujuta B Wilson; Carly Hyde; Edwin H Cook; Ronald L Thibert; Lawrence T Reiter; Vanessa Vogel-Farley; Joerg Hipp; Shafali Jeste Journal: Am J Med Genet A Date: 2019-10-26 Impact factor: 2.802
Authors: Matti Sillanpää; Bruce Hermann; Juha O Rinne; Riitta Parkkola; Maiju M Saarinen; Mira Karrasch; Jani Saunavaara; Eero Rissanen; Juho Joutsa; Shlomo Shinnar Journal: Acta Neurol Scand Date: 2021-11-26 Impact factor: 3.915